Zortix
Sign in
GSKNEUTRALBULLISHIn depth · 4/5

Yamanaka factors advance to human clinical trial

Life Biosciences secured FDA clearance to initiate human trials for cell-rejuvenating Yamanaka factors, marking a breakthrough in longevity science.

Sign in to read the full idea

The argument, what validates it, the risks discussed and hearing it from the source are for signed-in members. Free accounts read 3 ideas in full a day — no card required.

NOT INVESTMENT ADVICE · A SUMMARY OF WHAT WAS SAID ON THE PODCAST · VERIFY AGAINST THE SOURCE
GSK: Yamanaka factors advance to human clinical trial · Zortix